The global vaginitis therapeutics market size is expected to reach USD 4.21 billion by 2025, according to a new report by Grand View Research, Inc. It is estimated to expand at a CAGR of 8.4% during the forecast period. Supportive initiatives by government and non-government agencies to increase awareness level among women is driving the demand for vaginitis drugs. Increased consumption of alcohol is also estimated to fuel the adoption of these drugs. Around 5.3 million women in the U.S. are at risk related to health and general well-being.
Furthermore,
rising R&D activities for vaginitis therapeutics is anticipated to
accelerate the market growth. National Institute of Allergy and Infectious
Diseases (NIAID)-funded research has discovered various important data about
yeast generative behavior, which could result in new way of treatment for yeast
infections. In addition, introduction of new drugs by key companies is expected
to propel the market growth. For instance, in September 2017, Symbiomix
Therapeutics received FDA approval for Solosec (secnidazole) for the treatment
of bacterial vaginosis.
Full Research Report On Vaginitis Therapeutics Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/vaginitis-therapeutics-market
Vaginitis
Therapeutics Market Report Highlights
- Anti-bacterial
segment led the market in 2017 owing to the availability of a wide product
range and higher number of cases of bacterial vaginosis disease
- Hormone is
expected to witness lucrative growth with a CAGR of 9.1% over the forecast
period due to the presence of pipeline products and rising adoption of
products
- Prescription
type held the largest market share in 2017, in terms of revenue. The
segment was valued at USD 1.14 billion owing to the higher efficacy and
safety of prescribed drugs and availability of a wide range of drugs for
severe and recurring vaginitis
- Over the
counter is expected to be the fastest-growing type in the coming years
with a CAGR of 8.7% due to increasing number of FDA approvals for the
treatment of mild vaginitis
- North America
is estimated to be the largest regional market. It was the dominant region
in 2017, in terms of revenue, owing to of high-quality healthcare services
and increasing cases of vaginitis
- Asia Pacific
is expected to be the fastest-growing region registering a lucrative CAGR
over the forecast period. This growth is attributed to favorable
government initiatives and rising disposable income along with the presence
of a large target population base.
- Key players
in the vaginitis therapeutics market are Pfizer, Inc.; Merck & Co.;
Novartis AG; Bayer AG; Lupin Pharmaceuticals, Inc.; Symbiomix
Therapeutics, Inc.; and Mission Pharmacal Company
- Most of these
companies focus on strategic initiatives, such as collaborations, M&A,
and product portfolio expansion. For instance, in October 2017, Lupin
Pharmaceuticals acquired Symbiomix Therapeutics to expand its product
portfolio.
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/vaginitis-therapeutics-market/request/rs1
Vaginitis
Therapeutics Market Segmentation
Grand View Research has
segmented the global vaginitis therapeutics market on the basis of product,
type, and region:
Vaginitis
Therapeutics Product Outlook (Revenue, USD Million, 2014 - 2025)
- Anti-fungal
- Anti-bacterial
- Hormone
Vaginitis
Therapeutics Type Outlook (Revenue, USD Million, 2014 - 2025)
- Over-The-Counter (OTC)
- Prescription (Rx)
Vaginitis
Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment